Skip to content

Unipharma

Active
Private limited companyfounded 1969active for 57 yearsRue de la Ville 6, 5660 Couvin, BelgiumKBO/BCE: BE 0406.125.637
Summary

Unipharma has been active since 1969 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €798,860 and a net result of €91,588. Equity is growing by about 3.5% per year across the filed financial years. Its solvency ranks better than 40% of 4,103 sector peers (NACE 69, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
UnipharmaActiveChecked score 89/100
Risk analysis ReportCompare

Overview

Activity
Other legal services
NACE 69109Retail sale of pharmaceutical products NACE 47730
Oldest company in Couvin, Professional and technical services sector4 sites
Size
€2.5mtotal assets 2025
Staff
14.5 FTE
Equity
€798,860
Profit
€91,588
Financial health
89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Structure
Holdings
1
2025 accounts filed 27 days late3 of 8 deeds summarised
Why 89raises riskLiquidity: current ratio 0.98, cash €148,141Size: 14.5 FTE, total assets €2.5mlowers riskSector: Legal and accounting activities (NACE 69)Figures for financial year 2025 (filed 27-08-2026)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 39% of its sector peers (NACE 69, small)
Every signal that counts is listed under Signals.
Financial strength · tick = 2024
Strong
Solvency 58+5
equity 32.6% of total assets
Liquidity 42+1
short-term debt 34.1% · cash 6.0%
Profitability 73=
return on assets 3.7%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,478 companies, NACE 69, small)
Last 24 months 11-2024: 0.5% 12-2024: 0.5%● unchanged vs 11-2024 01-2025: 0.5%● unchanged vs 12-2024 02-2025: 0.5%● unchanged vs 01-2025 03-2025: 0.5%● unchanged vs 02-2025 04-2025: 0.5%● unchanged vs 03-2025 05-2025: 0.5%● unchanged vs 04-2025 06-2025: 0.5%● unchanged vs 05-2025 07-2025: 0.6%▲ +0.1 percentage points vs 06-2025 08-2025: 0.9%▲ +0.3 percentage points vs 07-2025highest value 09-2025: 0.2%▼ -0.7 percentage points vs 08-2025 10-2025: 0.2%● unchanged vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.3%▲ +0.1 percentage points vs 06-2026 08-2026: 0.5%▲ +0.2 percentage points vs 07-2026 09-2026: 0.2%▼ -0.3 percentage points vs 08-2026lowest value 10-2026: 0.2%● unchanged vs 09-2026lowest value
Credit of up to €70,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.98, compared with 1.02 in 2024, below 1; short-term debt: 34.1% and cash: 6% of total assets), and 67.4% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 69, small): better than 37% on solvency, 21% on liquidity, 34% on profitability and 63% on growth.

The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises risk
lowers risk · Sector: Legal and accounting activities (NACE 69)
KBO
raises risk · Liquidity: current ratio 0.98, cash €148,141
NBB · annual accounts
raises risk · Size: 14.5 FTE, total assets €2.5m
Companies of this size fail more often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 27-08-2026)
NBB · annual accounts
raises risk · 2025 accounts filed 27 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
27 days late
2024
28 days late
2023
26 days late
2022
59 days late
2021
80 days late
2020
30 days late
2019
91 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 49 days after the deadline; the sector median (NACE 69) for financial year 2024 is 9 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 28 August (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Where today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Accounting effect · Other provisionMerger
  2. Annual accounts filedfinancial year 2025 · abbreviated…
  3. Annual accounts filedfinancial year 2024 · full…

Key points

  • Positive: Oldest company in Couvin, Professional and technical services sectorin the Checked rankings No. 1 View
  • Positive: Staff rose in 2025from 10.8 FTE to 14.5 FTE ▲ 34.3% View
  • Active since 1969founded 27-01-1969 57 years View

By topic

Financials

Financial year
2025
Total assets
€2.5m
Profit
€91,588
Solvency
32.6%
Total assets▼ 1.9%
Net result
20182025
Go to Financials

Board & ownership

Board
3 members
  • GAYE Jean-CharlesDirector
  • MONIN François Joseph Michel ChristianDirector
  • STAQUET Laurent Victor EdouardDirector
Go to Board & ownership

Network & group

Subsidiaries
1
Connected companies
3
Mergers and asset contributions
1

1 subsidiary

Go to Network & group

Timeline

Events
55
Since
1978
Next accounts
by 31-07-2027
  1. 19-03-2025Resignation: Anne Coppe (director)
  2. 31-12-2024Back to profit
  3. 26-08-2024Annual accounts filed
Go to Timeline

Company details

Sites
4
Legal form
Private limited company
Activity
Other legal servicesNACE 69109
Founded
27-01-1969
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Articles of association

Provisions read
23
Annual meeting
Last Thursday of May at 18:00
Purpose
L'achat et la vente au détail de produits et d'accessoires pharmaceutiques ou…
Go to Articles of association

Key facts about Unipharma

What is the company number of Unipharma?
0406.125.637. In Belgium the VAT number is the company number with BE in front: BE 0406.125.637.
Where is Unipharma based?
The registered office is at Rue de la Ville 6, 5660 Couvin.Company details
What does Unipharma do?
According to the KBO register, the main activity is other legal services (NACE 69109).
What is the legal form of Unipharma?
Private limited company (BV).
When was Unipharma founded?
On 27-01-1969.
Is Unipharma still active?
Yes, Unipharma is an active enterprise in the KBO register.
How many employees does Unipharma have?
On average 14.5 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Unipharma?
Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
Is Unipharma profitable?
In financial year 2025, Unipharma made a profit of €91,588.
Where can I find the annual accounts of Unipharma?
Unipharma filed 48 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Unipharma due?
By 31-07-2027, for financial year 2026.Timeline

Companies related to Unipharma

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Is the workforce growing, and do people stay?Employer check Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure